Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 2,252† | 2,183† | 2,019† | 1,854† | 1,598† |
| Net profit | 286 | 274 | 307 | 201 | 220† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Ameya Ashok Chandavarkar | Executive Director | June 30, 2026 |
| Ashok Anand Chandavarkar | Executive Director | June 30, 2026 |
| Mohan Anand Chandavarkar | Executive Director | June 30, 2026 |
| Nandan Mohan Chandavarkar | Executive Director | June 30, 2026 |
| Charuta Nityanath Mandke | Independent Director | June 30, 2026 |
| Kishore Mukund Saletore | Independent Director | June 30, 2026 |
| Mahesh Chandru Bijlani | Independent Director | June 30, 2026 |
| Vijay Nautamlal Bhatt | Independent Director | June 30, 2026 |
| Vijay Suresh Maniar | Independent Director | June 30, 2026 |
| Nomita Ramdas Chandavarkar | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
